Literature DB >> 1688474

Creation of an antigenic site in poliovirus type 1 by assembly of 14 S subunits.

B Rombaut1, A Boeyé, M Ferguson, P D Minor, A Mosser, R Rueckert.   

Abstract

Using a set of neutralizing monoclonal antibodies targeted against the four known antigenic sites of poliovirus type 1, it was shown that three out of four antigenic sites are already present on 14 S subunits (pentamers of the structural unit). Site 3B, in contrast, is formed upon assembly of 14 S subunits into capsids. The data support the hypothesis that site 3B spans the boundary between pentamers in the virion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688474     DOI: 10.1016/0042-6822(90)90080-b

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  Molecular basis of antigenic structures of poliovirus: implications for their evolution during morphogenesis.

Authors:  K Wiegers; R Dernick
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

2.  Myristoylation is important at multiple stages in poliovirus assembly.

Authors:  N Moscufo; J Simons; M Chow
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

3.  Antigenic and immunogenic properties of recombinant hepatitis A virus 14S and 70S subviral particles.

Authors:  J T Stapleton; V Raina; P L Winokur; K Walters; D Klinzman; E Rosen; J H McLinden
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

4.  Monoclonal antibodies that disrupt poliovirus only at fever temperatures.

Authors:  I Delaet; A Boeyé
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

5.  Postabsorption neutralization of poliovirus.

Authors:  R Vrijsen; A Mosser; A Boeyé
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

6.  Increasing Type 1 Poliovirus Capsid Stability by Thermal Selection.

Authors:  Oluwapelumi O Adeyemi; Clare Nicol; Nicola J Stonehouse; David J Rowlands
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.